[Skip to Content]
[Skip to Content Landing]
June 1994

Hepatopancreatoduodenectomy for Advanced Gallbladder Carcinoma

Author Affiliations

From the Second Departments of Surgery (Drs Nakamura, Nishiyama, Yokoi, Serizawa, Nishiwaki, Konno, and Baba) and Pathology (Dr Muro), Hamamatsu (Japan) University School of Medicine.

Arch Surg. 1994;129(6):625-629. doi:10.1001/archsurg.1994.01420300069010

Objective:  To assess the effectiveness of hepatopancreatoduodenectomy (HPD) in patients with advanced gallbladder carcinoma directly invading the liver and pancreas, generally considered to be nonresectable.

Patients and Methods:  Sixty patients with gallbladder carcinoma admitted to our hospital from 1978 to 1992, of whom 55 had Nevin stage V carcinoma and 21 had resectable tumors. Of these patients, seven underwent HPD. The remaining 34 patients had nonresectable tumors. The outcomes of patients undergoing HPD and those with nonresectable tumors were compared and the effect on their quality of life was also analyzed.

Results:  Postoperative complications occurred in five of the seven patients after HPD, but there were no operative deaths. The 1- and 2-year survival rates were 57% and 28.6%, respectively, with a median survival time of 12 months. In contrast, the 1- and 2-year survival rates of the 34 patients with nonresectable tumors were both 5.8%, and the median survival time was 2 months. The median and mean durations of home stay after HPD were 6 and 10.5 months, respectively.

Conclusion:  Hepatopancreatoduodenectomy has the potential to improve both survival and the quality of life for carefully selected patients with advanced gallbladder carcinoma.(Arch Surg. 1994;129:625-629)